Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Chong Wei, Wei Zhang & Daobin Zhou. (2020) Central nervous system involvement at diagnosis in extranodal natural killer/T-cell lymphoma: a single-center study. Leukemia & Lymphoma 61:13, pages 3272-3274.
Read now
Read now
Elisa Santambrogio, Maura Nicolosi, Francesco Vassallo, Alessia Castellino, Mattia Novo, Annalisa Chiappella & Umberto Vitolo. (2019) Aggressive Non-Hodgkin lymphomas: risk factors and treatment of central nervous system recurrence. Expert Review of Hematology 12:9, pages 787-796.
Read now
Read now
Gyeong-Won Lee, Se-Il Go, Seok-Hyun Kim, Junshik Hong, Yu Ri Kim, Sukjoong Oh, Sung-Yong Kim, Young Rok Do, Hyewon Lee, Soon Il Lee, Sung Hwa Bae, Sung Yong Oh, Moo Kon Song, Won-Sik Lee, Bohee Lee, Jin Seok Kim, Min Kyoung Kim, Hye Jin Kang, Jae-Sook Ahn, Ho-Young Yhim, Hyo Jung Kim, Seok Jin Kim, Won Seog Kim & Cheolwon Suh. (2015) Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma. Leukemia & Lymphoma 56:4, pages 1020-1026.
Read now
Read now
Kristoph Jahnke & Eckhard Thiel. (2009) Treatment options for central nervous system lymphomas in immunocompetent patients. Expert Review of Neurotherapeutics 9:10, pages 1497-1509.
Read now
Read now
Alan Peleg, Manraj K.S. Heran, Valerie A. White, Wilma Y. Chang & Jack Rootman. (2009) Malignant Lymphoproliferative Disorders Extending into the Orbit from the Paranasal Sinuses. Orbit 28:2-3, pages 80-87.
Read now
Read now
Koen Van Besien, Christian Gisselbrecht, Michael Pfreundschuh & Emanuele Zucca. (2008) Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment. Leukemia & Lymphoma 49:sup1, pages 52-58.
Read now
Read now
Articles from other publishers (34)
Boxiao Chen, Yili Fan, Luyao Wang, Jiawei Zhang, Dijia Xin, Xi Qiu, Huawei Jiang, Baizhou Li, Qin Chen, Chao Wang, Xibin Xiao, Liansheng Huang & Yang Xu. (2023) Case Report: Radiation necrosis mimicking tumor progression in a patient with extranodal natural killer/T-cell lymphoma. Frontiers in Radiology 3.
Crossref
Crossref
Rory Bennett, Anna Ruskova, Christin Coomarasamy, Edward Theakston, Leanne Berkahn, Sharon Jackson, Mina Christophers, Stephen Wong & Samar Issa. (2023)
Diffuse large B‐cell lymphoma at risk of secondary
CNS
involvement: The inefficacy of intravenous high‐dose methotrexate
CNS
prophylaxis and the importance of baseline cerebrospinal fluid analysis
. American Journal of Hematology 98:7, pages 1070-1079.
Crossref
Crossref
Todd Spock, Alfred Marc Iloreta, Brett A. Miles & Mohemmed Khan. 2023. ENT Board Prep. ENT Board Prep
409
422
.
Si‐Yuan Chen, Meng‐Meng Ji, Peng‐Peng Xu & Wei‐Li Zhao. (2022) Primary extranodal diffuse large B‐cell lymphoma: Molecular features, treatment, and prognosis. Aging and Cancer 3:3-4, pages 133-146.
Crossref
Crossref
Takafumi Shichijo, Hiro Tatetsu, Kisato Nosaka, Yusuke Higuchi, Yoshitaka Kikukawa, Yoshitaka Inoue, Kosuke Toyoda, Jun‐ichirou Yasunaga & Masao Matsuoka. (2022) Predictive impact of soluble interleukin‐2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B‐cell lymphoma. eJHaem 3:2, pages 385-393.
Crossref
Crossref
Akiko Aoki, Hiroshi Kobayashi, Shine Abe, Takayuki Kimura, Takeshi Taguchi & Hidehiro Yuuta. (2022) A case of methotrexate-associated diffuse large B-cell lymphoma with splenial lesions of the corpus callosum on brain MRI after complete remission with chemotherapy化学療法で完全寛解後にMRIで脳梁膨大部病変が描出されたメトトレキサート関連びまん性大細胞型B細胞性リンパ腫の症例. Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 59:1, pages 96-101.
Crossref
Crossref
Hyehyun Jeong, Hyungwoo ChoHyeyeong KimHeejung ChaeJung-Bok LeeKyoungmin Lee, Shin KimSang-wook LeeJin-Sook Ryu, Kyung Won Kim, Eun Jin Chae, Jooryung Huh, Chan-Sik Park, Dok Hyun YoonCheolwon Suh. (2021) Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent–based analysis. Blood Advances 5:8, pages 2142-2152.
Crossref
Crossref
Farzaneh Ashrafi, Christoph Klein, Mohaddese Poorpooneh, Roya Sherkat & Razieh Khoshnevisan. (2020) A case report of sinusoidal diffuse large B-cell lymphoma in a STK4 deficient patient. Medicine 99:9, pages e18601.
Crossref
Crossref
Pauli Vähämurto, Susanna Mannisto, Marjukka Pollari, Marja‐Liisa Karjalainen‐Lindsberg, Antti A. Mäkitie & Sirpa Leppä. (2019) Clinical features and outcome of the patients with sinonasal tract diffuse large B‐cell lymphoma in the pre‐rituximab and rituximab eras. European Journal of Haematology.
Crossref
Crossref
Thomas A. Ollila & Adam J. Olszewski. (2018) Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence. Current Treatment Options in Oncology 19:8.
Crossref
Crossref
B Liu, L Dong, W Shi, J Lv, L Guo & M Liu. (2018) Primary maxillary sinus lymphoma. QJM: An International Journal of Medicine 111:2, pages 119-120.
Crossref
Crossref
Masanobu Uchiyama, Miho Ueno, Yasushi Takamatsu, Koichi Matsuo, Osamu Imakyure & Hidetoshi Kamimura. (2018) A Survey of the Adverse Effects and Influence of Concomitant Drugs for Methotrexate Intrathecal AdministrationMethotrexate髄腔内投与での副作用発現症例における併用薬の影響. YAKUGAKU ZASSHI 138:1, pages 111-115.
Crossref
Crossref
Kerry J. Savage. (2017) Secondary CNS relapse in diffuse large B-cell lymphoma: defining high-risk patients and optimization of prophylaxis strategies. Hematology 2017:1, pages 578-586.
Crossref
Crossref
Norbert Schmitz, Maike Nickelsen & Kerry J. Savage. (2016) Central Nervous System Prophylaxis for Aggressive B-cell Lymphoma. Hematology/Oncology Clinics of North America 30:6, pages 1277-1291.
Crossref
Crossref
Chao Li, Lin Li, Ping Zhang, Jin-Song Zhang, Ting Gao, Yan Xu & Wen-Chan Li. (2016) Multifocal extranodal lymphoma. Medicine 95:40, pages e5029.
Crossref
Crossref
Fredrik Ellin, Jenny Landström, Mats Jerkeman & Thomas Relander. (2015) Central nervous system relapse in peripheral T-cell lymphomas: a Swedish Lymphoma Registry study. Blood 126:1, pages 36-41.
Crossref
Crossref
Arshpreet Kaur & Asha Thomas. (2015) Diffuse Large B-Cell Lymphoma Presenting with Diabetes Insipidus: A Case Report. AACE Clinical Case Reports 1:2, pages e111-e114.
Crossref
Crossref
Niels MurawskiGerhard HeldMarita ZiepertBarbara KempfAndreas ViardotMathias HänelMathias Witzens-HarigRolf MahlbergChristian Rübe, Jochen Fleckenstein, Carsten ZwickBertram Glass, Norbert Schmitz, Samira ZeynalovaMichael Pfreundschuh. (2014) The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas. Blood 124:5, pages 720-728.
Crossref
Crossref
Chan Yoon Cheah, John F Seymour & Michael Dickinson. (2014) Ongoing challenge of optimal patient selection for CNS prophylaxis in patients with non-Hodgkin lymphoma. International Journal of Hematologic Oncology 3:3, pages 189-201.
Crossref
Crossref
Andrés J M Ferreri. (2014) Risk of CNS dissemination in extranodal lymphomas. The Lancet Oncology 15:4, pages e159-e169.
Crossref
Crossref
M. Mian, D. Capello, M. B. Ventre, D. Grazio, M. Svaldi, A. Rossi, R. Tsang, M. K. Gospodarowicz, E. Oldani, M. Federico, S. Luminari, L. Marcheselli, E. M. Pogliani, F. Rossini, M. E. Cabrera, M. Martelli, G. Gutierrez-Garcia, M. Busetto, C. Visco, M. Fiegl, D. Rossi, G. Gaidano, F. Cavalli, E. Zucca, A. Rambaldi & S. Cortelazzo. (2013) Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study). Annals of Hematology 93:2, pages 221-231.
Crossref
Crossref
Alfred M. Iloreta & Brett A. Miles. 2014. ENT Board Prep. ENT Board Prep
247
257
.
Joseph M Connors. (2013) Non-Hodgkin lymphoma: the clinician's perspective—a view from the receiving end. Modern Pathology 26, pages S111-S118.
Crossref
Crossref
Hanny Haaxma-Reiche. 2012. Neuro-Oncology Part II. Neuro-Oncology Part II
711
729
.
J.H. Yi, J.H. Kim, K.K. Baek, T. Lim, D.J. Lee, Y.C. Ahn, K. Kim, S.J. Kim, Y.H. Ko & W.S. Kim. (2011) Elevated LDH and paranasal sinus involvement are risk factors for central nervous system involvement in patients with peripheral T-cell lymphoma. Annals of Oncology 22:7, pages 1636-1643.
Crossref
Crossref
Judith A. Ferry. 2011. Extranodal Lymphomas. Extranodal Lymphomas
34
80
.
D. Villa, J.M. Connors, T.N. Shenkier, R.D. Gascoyne, L.H. Sehn & K.J. Savage. (2010) Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy. Annals of Oncology 21:5, pages 1046-1052.
Crossref
Crossref
S.J. Kim, S.Y. Oh, J.Y. Hong, M.H. Chang, D.H. Lee, J. Huh, Y.H. Ko, Y.C. Ahn, H.-J. Kim, C. Suh, K. Kim & W.S. Kim. (2010) When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?. Annals of Oncology 21:5, pages 1058-1063.
Crossref
Crossref
Nancy L. Bartlett. 2010. Cummings Otolaryngology - Head and Neck Surgery. Cummings Otolaryngology - Head and Neck Surgery
1673
1681
.
Anna Laurell. 2010. Otorhinolaryngology, Head and Neck Surgery. Otorhinolaryngology, Head and Neck Surgery
623
628
.
Valérie Costes. (2009) Pathologie lymphoïde de la tête et du cou. Annales de Pathologie 29:4, pages 323-334.
Crossref
Crossref
Luca Cimino, Chi-Chao Chan, DeFen Shen, Luciano Masini, Fiorella Ilariucci, Maurizio Masetti, Silvia Asioli, Antonio Sartori & Luca Cappuccini. (2008) Ocular involvement in nasal natural killer T-cell lymphoma. International Ophthalmology 29:4, pages 275-279.
Crossref
Crossref
P. ChierigoL. NicolardiM. RahmatiM. LazzarottoD. BrotzaF. BassanN. Franzolin. (2018) Testicular Localization of Extranodal Multifocal Non-Hodgkin Lymphoma. Report of Two Cases, Review of the Literature and Clinical Considerations. Urologia Journal 76:2, pages 133-136.
Crossref
Crossref
Tamara N. Shenkier & Joseph M. Connors. 2006. The Lymphomas. The Lymphomas
325
347
.